Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting KRAS in pancreatic cancer: Emerging therapeutic strategies

Advances in cancer research(2023)10.1016/bs.acr.2023.02.004Source: DataRank Database

Targeting KRAS in pancreatic cancer: Emerging therapeutic strategies is a research paper published in Advances in cancer research (2023). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

19 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 13.14)OA: closedTopics (38)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Vivekananda Budamagunta,Daohong Zhou ORCID,Sajid Khan ORCID

Live enrichment

PubMed:37268395 OpenAlex:https://openalex.org/W4323781835

National Cancer Institute

Grant: P30CA054174

National Cancer Institute

Grant: R01CA219836

National Cancer Institute

Grant: R01CA241191

National Cancer Institute

Grant: R01CA242003

FWCI

13.14

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S0065230X23000180?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0065230X23000180?httpAccept=text/plain

book serieshttps://doi.org/10.1016/bs.acr.2023.02.004

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37268395

Fields of Study

Cancer therapeutics and mechanismsPI3K/AKT/mTOR signaling in cancerCell death mechanisms and regulationHumansCarcinoma, Non-Small-Cell LungLung NeoplasmsMutationPancreatic NeoplasmsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins p21(ras)Heterocyclic Compounds, 2-RingNaphthalenes

MeSH Terms

Carcinoma, Non-Small-Cell LungHeterocyclic Compounds, 2-RingHumansLung NeoplasmsMutationNaphthalenesPancreatic NeoplasmsProto-Oncogene Proteins p21(ras)Phosphatidylinositol 3-Kinases

Keywords

KRASPancreatic cancerCancer researchCancerPI3K/AKT/mTOR pathwayOncogeneTargeted therapyCancer cellCell cycleBiologySignal transductionColorectal cancerGeneticsCombinatorial therapyDrug resistanceOncogenic signalingSenescence

Sustainable Development Goals

SDG 0: Good health and well-being

Targeting KRAS in pancreatic cancer: Emerging therapeutic strategies

FAIR Checklist

Authors (3)

Funding (4 grants)

Impact

Open Access

Topics